HHS publishes guidelines to lower prescription prices

HHS publishes guidelines to lower prescription prices
August 03 14:09 2020 Print This Article

President Donald Trump recently signed Executive Orders directing the Department of Health and Human Services (HHS) to publish guidelines to facilitate lower prices for prescription medicines. One of the key elements is bypassing the Pharmacy Benefit Managers, industry middlemen who drive up drug prices an estimate 26 to 30 percent.

Other measures include using government bulk purchasing power to reduce the cost of insulin and epinephrine injectors, codifying that Medicare patients will pay no more for prescriptions than patients pay in other industrialized countries and allowing state Medicaid systems to import medicines from other countries at a lower cost.

“President Trump has already done more than any other President to lower drug costs,” said HHS Secretary Alex Azar. “No President has ever taken action on drug prices as bold as (these measures). The President’s new efforts to cut drug costs are about making it affordable for American patients be in control of their own health, their own healthcare choices, and the care they decide on with their own doctors.” The cost reduction measures were strongly opposed by the American pharmaceutical industry.